Indeed, we found an increased total number of TCD3+ lymphocytes in the peripheral blood, particularly the TCD4+ subpopulation, and higher plasma levels of anti-inflammatory IL-10 but not pro-inflammatory IL-6 in rats with the ICV-STZ model of AD at Day 90 post-injection supporting such an anti-inflammatory effect. This evidence concerns the gene IL10 and Alzheimer disease.